About Indaptus Therapeutics, Inc. - Common Stock (INDP)
Indaptus Therapeutics Inc. is a biopharmaceutical company focused on developing innovative therapies for patients with serious and life-threatening diseases. The company specializes in leveraging advanced technologies to create novel treatments that aim to harness the body's immune system and improve therapeutic outcomes. By advancing its pipeline of drug candidates, Indaptus Therapeutics seeks to address unmet medical needs and provide new hope for patients suffering from various forms of cancer and other challenging conditions. Read More
Looking for insights into the US markets in the middle of the day on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
The session on Tuesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
Gainers Enanta Pharma (NASDAQ: ENTA) stock rose 15.6% to $9.13 during Friday's after-market session. The market value of their outstanding shares is at $165.6 million.
As the regular session of the US market on Friday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Gainers Indaptus Therapeutics (NASDAQ: INDP) stock moved upwards by 108.1% to $6.83 during Friday's regular session. The market value of their outstanding shares is at $3.6 million.
